mRNA vaccines proved safe and effective during COVID, review says. Cancer could be next
A review published in The Lancet confirms the safety and high effectiveness of mRNA COVID-19 vaccines between 2020 and 2025. Researchers suggest the underlying technology holds significant promise for future cancer treatments.
Why it matters
Validating the efficacy of mRNA technology provides a foundation for future medical breakthroughs beyond infectious diseases.
Dr. Manish Sadarangani, director of the Vaccine Evaluation Centre at B.C. Children's Hospital, and his co-authors combed through published data from laboratory research, clinical trials and real-world surveillance from Pfizer-BioNTech’s and Moderna’s mRNA vaccines from January 2020 through December 2025 to assess their scientific and public health impacts.
The article relies on peer-reviewed medical data and expert commentary to present a balanced view of vaccine performance.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in